Kiang-Teck Jerry Yeo to Reproducibility of Results
This is a "connection" page, showing publications Kiang-Teck Jerry Yeo has written about Reproducibility of Results.
Connection Strength
0.428
-
Losing sight of the Forest for the trees: Why clinical laboratories need to perform their own interference studies. Clin Chim Acta. 2018 08; 483:239-240.
Score: 0.102
-
Analytical validation of soluble fms-like tyrosine and placental growth factor assays on B·R·A·H·M·S KRYPTOR Compact Plus automated immunoassay platform. Pregnancy Hypertens. 2018 Jan; 11:66-70.
Score: 0.100
-
Clinical evaluation of the QMS® Tacrolimus immunoassay. Clin Chim Acta. 2014 Apr 20; 431:270-5.
Score: 0.076
-
Comparison of performance of three commercial platforms for warfarin sensitivity genotyping. Clin Chim Acta. 2009 Aug; 406(1-2):143-7.
Score: 0.055
-
Validation of a CYP2D6 genotyping panel on the NanoChip Molecular Biology Workstation. Clin Chem. 2007 May; 53(5):823-8.
Score: 0.047
-
Validation of a Large Custom-Designed Pharmacogenomics Panel on an Array Genotyping Platform. J Appl Lab Med. 2021 11 01; 6(6):1505-1516.
Score: 0.032
-
A multicenter comparison of established and emerging cardiac biomarkers for the diagnostic evaluation of chest pain in the emergency department. Am Heart J. 2011 Aug; 162(2):276-282.e1.
Score: 0.016